Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196105 · ClinicalTrials.gov registry record · NA
Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT00196105 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 241 participants.
The verdict
NCT00196105, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
This study compares the 6 mm nitinol Zilver biliary endoprostheses and the 10 mm nitinol Zilver biliary endoprostheses to the 10 mm Wallstent in appropriate patients in need of palliative treatment of malignant obstructive jaundice.
Interventions
- DEVICE 6 mm Nitinol Zilver Stent
- DEVICE 10 mm Nitinol Zilver Stent
- DEVICE 10 mm Stainless Steel Wallstent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196105
The ClinicalTrials.gov registry entry for NCT00196105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 6 mm Nitinol Zilver Stent is the first listed.
NCT00196105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00196105 about?
NCT00196105 is a clinical study titled "Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)". This study compares the 6 mm nitinol Zilver biliary endoprostheses and the 10 mm nitinol Zilver biliary endoprostheses to the 10 mm Wallstent in appropriate patients in need of palliative treatment of malignant obstructive jaundice.
What is the current status of trial NCT00196105?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2003-09. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00196105?
The interventions under investigation include: 6 mm Nitinol Zilver Stent (DEVICE), 10 mm Nitinol Zilver Stent (DEVICE), 10 mm Stainless Steel Wallstent (DEVICE).
Who is sponsoring clinical trial NCT00196105?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.